Biotechnology News PIOGLITAZONE Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-3 out of 3 found

Current Search: pioglitazone: 3

Scientists at Nihon University release new data on obesity and diabetes therapy
- (NewsRx.com) -- Research findings, 'Clinical investigation of the effects of pioglitazone on the improvement of insulin resistance and blood pressure in type 2-diabetic patients undergoing hemodialysis,' are discussed in a new report (see...

Calibre Macro World: Oct 3 2008 1:56AM
Matching: pioglitazone

Find similar documents

Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hep
_ Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hep.

Diabetes: Sep 30 2008 8:50PM
Matching: pioglitazone

Find similar documents

EASD: Sitagliptin- Pioglitazone Combination Achieves Durable Glycemic Control
ROME, Sept.

12 -- Adding 50 mg of sitagliptin (Januvia) to pioglitazone (Actos) allowed patients with type 2 diabetes to achieve sustained glycemic control, a yearlong trial showed.

The 52-week data from Japan -- 40 weeks of which were...

MedPage Today: Sep 14 2008 5:57AM
Matching: pioglitazone

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.